Qinecsa is a global pharmacovigilance specialist, uniquely combining more than 20 years of scientific expertise with a flexible, technology-powered platform to solve complex drug safety challenges. By reducing fragmentation and delivering greater clarity and accountability, we enable pharma, biotech, and public health organisations to operate with confidence. As a dedicated, independent PV partner, Qinecsa is trusted by leading life sciences companies and health authorities worldwide to provide advanced solutions that elevate the standard of patient safety.
| Website | https://qinecsa.com/ |
| Revenue | $5.3 million |
| Employees | 945 (824 on RocketReach) |
| Founded | 2006 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Safety Technology, Scientific Expertise, Safety Solutions, Technology Products, Safety Products, Scientific Services, Lab Safety, Biosafety, Pharmaceutical Safety, Chemical Safety, Regulatory Compliance, Risk Management, Quality Assurance, Ehs Consulting, Environmental Health Safety, Laboratory Equipment, Scientific Equipment |
| Competitors | Deloitte, IBM, Cognizant, Oracle, Capgemini, Accenture, SAP, Tata Consultancy Services, Wipro, Infosys +47 more (view full list) |
Looking for a particular Qinecsa Solutions employee's phone or email?
The Qinecsa Solutions annual revenue was $5.3 million in 2026.
Adam Sherlock is the CEO of Qinecsa Solutions.
824 people are employed at Qinecsa Solutions.